Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 6, 2012, Pages 2365-2370

  Yamashita, Shin ichi ^a   Tokuishi, Keita ^b   Moroga, Toshihiko ^b   Yamamoto, Satoshi ^b   Ohbo, Kazuyuki ^b   Miyahara, S ^b   Yoshida, Yasuhiro ^b   Yanagisawa, Jun ^b   Hamatake, Daisuke ^b   Hiratsuka, Masafumi ^b   Yoshinaga, Yasuteru ^b   Shiraishi, Takeshi ^b   Iwasaki, Akinori ^b   Kawahara, Katsunobu ^b  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; PROTEIN; TUMOR MARKER; WFDC2 PROTEIN, HUMAN;

ADENOCARCINOMA; AGED; ARTICLE; BLOOD; CANCER STAGING; CASE CONTROL STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; MALE; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE;

ADENOCARCINOMA; AGED; CA-125 ANTIGEN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; PROTEINS; ROC CURVE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 85027935800     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0499-8     Document Type: Article

References (0)